智通财经APP获悉，英派药业-B(07630)涨近13%，截至发稿，涨11.14%，报14.87港元，成交额514.81万港元。
消息面上，英派药业今早公告，董事会获公司执行董事兼首席执行官蔡遂雄告知，其近期已于公开市场购买合共10万股公司普通股，每股股份平均价格为约14.6105港元，占公司已发行股份总数之约0.035%。蔡博士表示，其对集团的整体发展前景及潜在增长充满信心。此外，公司已获纳入恒生综合指数成份股，相关变动将于9月4日收市后实施、9月7日起生效，公司股份预期符合纳入沪港通及深港通交易的标准。
今年上半年，英派药业实现收入1.05亿元，同比增长316.8%；净亏损则同比收窄29.5%。值得一提的是，核心产品塞纳帕利自今年1月1日起纳入国家医保药品目录后快速放量，上半年，塞纳帕利在中国的销售收入达7040万元，同比增长877.8%。已覆盖内地所有省份及近1200家医疗机构。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.